9
Jul 2026
Ongoing research reveals that multifloral honey is a promising candidate for protecting human skin cells from premature ageing and cell damage caused by UV radiation, with the potential for developing future clinical and cosmetic applications.
9
Jul 2026
Today at ISSCR 2026, new preliminary clinical data was presented evaluating an induced pluripotent stem cell (iPSC)-derived CAR T-cell therapy for patients with treatment-resistant systemic sclerosis, a rare autoimmune disease with high mortality.
9
Jul 2026
A soft, wireless NIRS forehead patch tracked water-sensitive brain signals during 16 overnight home sleep recordings in four healthy men. The signals changed with EEG/EOG-defined sleep stages, suggesting a new way to study sleep-linked brain-fluid dynamics, although the device did not directly measure CSF flow or glymphatic clearance.
9
Jul 2026
Due to the lack of specific Western medicine therapies for post-coronavirus disease 2019 (COVID-19) syndrome in clinical practice, this study aimed to investigate the efficacy of traditional Chinese medicine (TCM) for post-COVID-19 syndrome using a cohort study design and to explore its clinical value in alleviating patients' symptoms and improving clinical outcomes.
9
Jul 2026
Modern medicine increasingly relies on targeted drug delivery - a process during which tiny particles (nanoparticles) transport drugs to specific parts of the body.
9
Jul 2026
In experiments in which physicians made decisions about treating hypothetical patients, the physicians tended to trust incorrect advice presented as being generated by artificial intelligence (AI), even after given the opportunity to notice that patient recovery data contradicted the recommendations.
9
Jul 2026
Newly developed microparticles can infiltrate stubborn bacterial matrices and release tiny oxygen bubbles to clean surfaces and wounds more efficiently than hydrogen peroxide or other cleaning agents alone, researchers at the University of Illinois Urbana-Champaign report.
9
Jul 2026
A network meta-analysis of nine randomized controlled trials found that once-weekly semaglutide showed the largest estimated weight-loss effect among GLP-1 receptor agonists tested in adults with mental illness and obesity or related metabolic risk. The authors cautioned that the findings remain preliminary because the evidence base was small, heterogeneous, and largely indirect.
9
Jul 2026
When schools closed in the spring of 2020 at the onset of the COVID-19 pandemic, the number of children and adolescents receiving mental health treatment in the United States fell by more than half.
9
Jul 2026
New research, led by scientists from the Seaver Autism Center for Research and Treatment at Mount Sinai and published June 28 in Autism Research, has estimated that Phelan-McDermid syndrome (PMS) affects approximately 1 in 7,300 people, making it dramatically more common than previous estimates suggested.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
